Following animal studies, we also characterized the effects of silencing UBQLN1 on cell viability in vitro using the human neuroblastoma SH-SY5Y cells, as well as the effects of increasing UBQLN1 in AD-related Aβ levels. The gene discussed is UBQLN1; the disease is neuroblastoma.